S Wortley1, G Wong, A Kieu, K Howard. 1. School of Public Health, University of Sydney, Camperdown, Australia, sally.wortley@sydney.edu.au.
Abstract
BACKGROUND: It is well established that screening is effective in reducing the incidence and mortality associated with colorectal cancer (CRC). National screening programs have been implemented in many countries; however, uptake remains an issue. Understanding patient preferences may assist in shaping screening programs and tailoring information about screening tests. OBJECTIVE: Our objective was to undertake a systematic review of discrete choice experiments (DCEs) of CRC screening. METHODS: A systematic review of DCEs of CRC screening was undertaken in an average-risk general population. The methodological qualities of the studies were assessed using a standard checklist outlining best practice for conjoint studies. RESULTS: Nine studies met the selection criteria. Meta-analysis was not possible due to the heterogeneity of the data and methods. However, in eight studies, attributes describing accuracy and/or clinical effectiveness were reported to be statistically significant. We also found that individuals were willing to trade-off other attributes such as an increased risk of complications to gain greater clinical benefits. Screening was also preferred to non-screening by the majority of respondents, regardless of the test used. CONCLUSIONS: Understanding and incorporating individuals' preferences in decision making is increasingly considered essential in the health field. Data from DCEs can provide valuable insights into the trade-offs individuals are willing to undertake in respect to CRC screening. Such insights can be used by decision makers to identify screening tests that could maximize informed uptake. It is likely that, with better reporting and evolving methodology, the contribution that DCEs can make to such debates will increase.
BACKGROUND: It is well established that screening is effective in reducing the incidence and mortality associated with colorectal cancer (CRC). National screening programs have been implemented in many countries; however, uptake remains an issue. Understanding patient preferences may assist in shaping screening programs and tailoring information about screening tests. OBJECTIVE: Our objective was to undertake a systematic review of discrete choice experiments (DCEs) of CRC screening. METHODS: A systematic review of DCEs of CRC screening was undertaken in an average-risk general population. The methodological qualities of the studies were assessed using a standard checklist outlining best practice for conjoint studies. RESULTS: Nine studies met the selection criteria. Meta-analysis was not possible due to the heterogeneity of the data and methods. However, in eight studies, attributes describing accuracy and/or clinical effectiveness were reported to be statistically significant. We also found that individuals were willing to trade-off other attributes such as an increased risk of complications to gain greater clinical benefits. Screening was also preferred to non-screening by the majority of respondents, regardless of the test used. CONCLUSIONS: Understanding and incorporating individuals' preferences in decision making is increasingly considered essential in the health field. Data from DCEs can provide valuable insights into the trade-offs individuals are willing to undertake in respect to CRC screening. Such insights can be used by decision makers to identify screening tests that could maximize informed uptake. It is likely that, with better reporting and evolving methodology, the contribution that DCEs can make to such debates will increase.
Authors: Patrick M Bossuyt; Johannes B Reitsma; David E Bruns; Constantine A Gatsonis; Paul P Glasziou; Les M Irwig; David Moher; Drummond Rennie; Henrica C W de Vet; Jeroen G Lijmer Journal: Ann Intern Med Date: 2003-01-07 Impact factor: 25.391
Authors: Deborah Marshall; John F P Bridges; Brett Hauber; Ruthanne Cameron; Lauren Donnalley; Ken Fyie; F Reed Johnson Journal: Patient Date: 2010-12-01 Impact factor: 3.883
Authors: L van Dam; L Hol; E W de Bekker-Grob; E W Steyerberg; E J Kuipers; J D F Habbema; M L Essink-Bot; M E van Leerdam Journal: Eur J Cancer Date: 2010-01 Impact factor: 9.162
Authors: Esther W de Bekker-Grob; Lieke Hol; Bas Donkers; Leonie van Dam; J Dik F Habbema; Monique E van Leerdam; Ernst J Kuipers; Marie-Louise Essink-Bot; Ewout W Steyerberg Journal: Value Health Date: 2009-11-12 Impact factor: 5.725
Authors: Alex Ghanouni; Samuel G Smith; Steve Halligan; Andrew Plumb; Darren Boone; Guiqing Lily Yao; Shihua Zhu; Richard Lilford; Jane Wardle; Christian von Wagner Journal: Expert Rev Med Devices Date: 2013-07 Impact factor: 3.166
Authors: Ji Cheng; Eleanor Pullenayegum; Deborah A Marshall; John K Marshall; Lehana Thabane Journal: BMC Med Res Methodol Date: 2012-02-20 Impact factor: 4.615
Authors: Kathy L Flitcroft; Les M Irwig; Stacy M Carter; Glenn P Salkeld; James A Gillespie Journal: BMC Gastroenterol Date: 2012-12-29 Impact factor: 3.067
Authors: Norma B Bulamu; Gang Chen; Tim Bright; Julie Ratcliffe; Adrian Chung; Robert J L Fraser; Björn Törnqvist; David I Watson Journal: J Gastrointest Surg Date: 2018-11-26 Impact factor: 3.452
Authors: Christine E Kistler; Thomas M Hess; Kirsten Howard; Michael P Pignone; Trisha M Crutchfield; Sarah T Hawley; Alison T Brenner; Kimberly T Ward; Carmen L Lewis Journal: Patient Prefer Adherence Date: 2015-07-15 Impact factor: 2.711
Authors: Michael P Pignone; Trisha M Crutchfield; Paul M Brown; Sarah T Hawley; Jane L Laping; Carmen L Lewis; Kristen Hassmiller Lich; Lisa C Richardson; Florence Kl Tangka; Stephanie B Wheeler Journal: BMC Health Serv Res Date: 2014-11-30 Impact factor: 2.655
Authors: Travis Hyams; Bruce Golden; John Sammarco; Shahnaz Sultan; Evelyn King-Marshall; Min Qi Wang; Barbara Curbow Journal: BMC Health Serv Res Date: 2021-07-29 Impact factor: 2.655